Excision BioTherapeutics

Excision BioTherapeutics is a private biotechnology company headquartered in San Francisco, California. With a team of 38 employees, Excision BioTherapeutics is dedicated to developing innovative gene editing therapeutics. The company's primary focus is on addressing the critical medical need for effective treatments against life-threatening diseases caused by viral infections. Excision BioTherapeutics aims to translate its research into safe and clinically effective medicines that can significantly improve the lives of patients worldwide. Excision BioTherapeutics distinguishes itself through its commitment to advancing gene editing technologies as a transformative approach to treating viral infections. The company leverages its expertise in gene editing to develop novel therapeutics with the potential to provide long-lasting solutions for patients battling these debilitating diseases. For more information about Excision BioTherapeutics and its groundbreaking research, please visit their website at excizion.bio.